Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Leeksma, AC"'
Autor:
Baliakas, P, Jeromin, S, Iskas, M, Puiggros, A, Plevova, K, Nguyen-Khac, F, Davis, Z, Rigolin, GM, Visentin, A, Xochelli, A, Delgado, J, Baran-Marszak, F, Stalika, E, Abrisqueta, P, Durechova, K, Papaioannou, G, Eclache, V, Dimou, M, Iliakis, T, Collado, R, Doubek, M, Calasanz, MJ, Ruiz-Xiville, N, Moreno, C, Jarosova, M, Leeksma, AC, Panayiotidis, P, Podgornik, H, Cymbalista, F, Anagnostopoulos, A, Trentin, L, Stavroyianni, N, Davi, F, Ghia, P, Kater, AP, Cuneo, A, Pospisilova, S, Espinet, B, Athanasiadou, A, Oscier, D, Haferlach, C, Stamatopoulos, K, ERIC European Res Initiative CLL
Publikováno v:
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Recent evidence suggests that complex karyotype (CK) defined by the presence of >= 3 chromosomal aberrations (structural and/or numerical) identified by using chromosome-banding analysis (CBA) may be relevant for treatment decision-making in chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9f9f689ecd14b481ee08ad2c93add567
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2924
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2924
Autor:
Leeksma AC; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Lymphoma and myeloma center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), The Netherlands., Derks IAM; Department of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Lymphoma and myeloma center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), The Netherlands., Garrick B; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA., Jongejan A; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Colombo M; Bristol Myers Squibb's Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Bloedjes T; Department of Pathology, Amsterdam University Medical Centers, Lymphoma and Myeloma Center Amsterdam (LYMMCARE), University of Amsterdam, The Netherlands., Trowe T; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA., Leisten JC; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Howarth M; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA., Malek M; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA., Mortensen DS; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Blease K; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Groza MC; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Narla RK; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Loos R; Bristol Myers Squibb's Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Moerland PD; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Guikema JEJ; Department of Pathology, Amsterdam University Medical Centers, Lymphoma and Myeloma Center Amsterdam (LYMMCARE), University of Amsterdam, The Netherlands., Kater AP; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Lymphoma and myeloma center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), The Netherlands., Eldering E; Department of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Lymphoma and myeloma center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), The Netherlands., Filvaroff EH; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Feb; Vol. 17 (2), pp. 284-297. Date of Electronic Publication: 2022 Dec 16.
Autor:
Leeksma AC; Department of Hematology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), Amsterdam, Netherlands., Derks IAM; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), Amsterdam, Netherlands., Kasem MH; Translational Functional Cancer Genomics, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Kilic E; Department of Ophthalmology and Clinical Genetics Erasmus MC, Rotterdam, Netherlands., de Klein A; Department of Ophthalmology and Clinical Genetics Erasmus MC, Rotterdam, Netherlands., Jager MJ; Department of Ophthalmology, LUMC, Leiden, Netherlands., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Centers, Location VUMC, Amsterdam, Netherlands., Jansen JH; Laboratory of Hematology, Department Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands., Navrkalova V; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Center of Molecular Medicine, CEITEC, Masaryk University, Brno, Czechia., Faber LM; Department of Internal Medicine, Rode Kruis Ziekenhuis, Beverwijk, Netherlands., Zaborsky N; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.; Department of Internal Medicine III with Haematology, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria.; Department of Internal Medicine III with Haematology, Cancer Cluster Salzburg, Salzburg, Austria., Egle A; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.; Department of Internal Medicine III with Haematology, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria.; Department of Internal Medicine III with Haematology, Cancer Cluster Salzburg, Salzburg, Austria., Zenz T; Department of Oncology and Haematology, University Hospital and University of Zurich, Zurich, Switzerland., Pospisilova S; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Center of Molecular Medicine, CEITEC, Masaryk University, Brno, Czechia., Abdel-Wahab O; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Kater AP; Department of Hematology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands., Eldering E; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), Amsterdam, Netherlands.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Jan 29; Vol. 10, pp. 609409. Date of Electronic Publication: 2021 Jan 29 (Print Publication: 2020).
Autor:
Leeksma AC; Amsterdam University Medical Centers, University of Amsterdam., Baliakas P; Dept of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden., Moysiadis T; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Puiggros A; Hospital del Mar, Barcelona., Plevova K; University Hospital Brno, Masaryk University, Brno, Czech Republic., Van der Kevie-Kersemaekers AM; Dept of Clinical Genetics, Amsterdam University Medical Centers, Univ of Amsterdam, The Netherlands., Posthuma H; Dept of Clinical Genetics, Amsterdam University Medical Centers, Univ of Amsterdam, The Netherlands., Rodriguez-Vicente AE; IBSAL, IBMCC, Centro de Investigación del Cancer, Universidad de Salamanca-CSIC, Spain., Tran AN; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Barbany G; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Mansouri L; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Gunnarsson R; Division of Clinical Genetics, Dept of Laboratory Medicine, Lund University, Lund, Sweden., Parker H; Cancer Genomics, Academic Unit of Cancer Sciences, University of Southampton, Southampton, UK., Van den Berg E; Dept of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands., Bellido M; Dept of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands., Davis Z; Dept of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Wall M; Cytogenetics department, St Vincent Hospital Melbourne, Victoria, Australia., Scarpelli I; Oncogenomic laboratory, Dept of Hematology, Lausanne University Hospital (CHUV), Switzerland., Österborg A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Hansson L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm., Jarosova M; University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Ghia P; Dept. of Experimental Oncology, IRCCS Ospedale San Raffaele, Università Vita-Salute, Milan., Poddighe P; Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, The Netherlands., Espinet B; Laboratori de Citogenetica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain., Pospisilova S; CEITEC, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Tam C; St Vincent Hospital Melbourne, Peter MacCallum Cancer Center, University of Melbourne, Australia., Ysebaert L; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Nguyen-Khac F; Service d'Hematologie Biologique, Hopital Pitié-Salpetriere, APHP, Paris, France., Oscier D; Dept of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Schoumans J; Oncogenomic laboratory, Dept of Hematology, Lausanne University Hospital (CHUV), Switzerland., Stevens-Kroef M; Radboud University Medical Center, Dept of Human Genetics, Nijmegen, The Netherlands., Eldering E; Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Rosenquist R; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Strefford JC; Cancer Genomics, Academic Unit of Cancer Sciences, University of Southampton., Mellink C; Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Kater AP; Hematology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
Publikováno v:
Haematologica [Haematologica] 2021 Jan 01; Vol. 106 (1), pp. 87-97. Date of Electronic Publication: 2021 Jan 01.
Autor:
Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Jeromin S; MLL Munich Leukemia Laboratory, Munich, Germany., Iskas M; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Puiggros A; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.; Grup de Recerca Translacional en Neoplàsies Hematològiques, Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Plevova K; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Nguyen-Khac F; Hematology Department and Sorbonne University, Hopital Pitie-Salpetriere, INSERM U1138, Paris, France., Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Rigolin GM; Hematology Section, St. Anna University Hospital, Ferrara, Italy., Visentin A; Hematology Division, Department of Medicine, University of Padua, Padua, Italy., Xochelli A; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Delgado J; Department of Hematology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain., Baran-Marszak F; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Stalika E; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Abrisqueta P; Servei d'Hematología, Hospital Vall d'Hebron, Barcelona, Spain., Durechova K; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Papaioannou G; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Eclache V; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Dimou M; Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Iliakis T; Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Collado R; Servicio de Hematología, Consorcio Hospital General Universitario, Valencia, Spain., Doubek M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Calasanz MJ; Servicio de Genética Citogenética, Departamento de Genética, Universidad de Navarra, Pamplona, Spain., Ruiz-Xiville N; Servei Laboratori Hematologia, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Moreno C; Servei d'Hematologia, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain., Jarosova M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Leeksma AC; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Panayiotidis P; Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Podgornik H; Department of Hematology, University Medical Centre Ljubljana, Ljubljana, Slovenia; and., Cymbalista F; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Anagnostopoulos A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Trentin L; Hematology Division, Department of Medicine, University of Padua, Padua, Italy., Stavroyianni N; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Davi F; Hematology Department and Sorbonne University, Hopital Pitie-Salpetriere, INSERM U1138, Paris, France., Ghia P; Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy., Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Cuneo A; Hematology Section, St. Anna University Hospital, Ferrara, Italy., Pospisilova S; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Espinet B; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.; Grup de Recerca Translacional en Neoplàsies Hematològiques, Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Athanasiadou A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Stamatopoulos K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
Publikováno v:
Blood [Blood] 2019 Mar 14; Vol. 133 (11), pp. 1205-1216. Date of Electronic Publication: 2019 Jan 02.
Autor:
Leeksma AC; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Taylor J; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu B; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Gardner JR; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., He J; Foundation Medicine, Inc., Cambridge, MA, USA., Nahas M; Foundation Medicine, Inc., Cambridge, MA, USA., Gonen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alemayehu WG; HOVON Data Center, Erasmus MC, Daniel Den Hoedkliniek, Rotterdam, The Netherlands., Te Raa D; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Walther T; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hüllein J; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Dietrich S; Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany., Claus R; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Haematology/Oncology, Augsburg Hospital, Augsburg, Germany., de Boer F; Department of Internal medicine, Ikazia Hospital, Rotterdam, The Netherlands., de Heer K; Department of Internal medicine, Flevo Hospital, Almere, The Netherlands., Dubois J; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Dampmann M; Department of Haematology, University Hospital Essen, Essen, Germany., Dürig J; Department of Haematology, University Hospital Essen, Essen, Germany., van Oers MHJ; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Geisler CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Eldering E; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Levine RL; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Miller V; Foundation Medicine, Inc., Cambridge, MA, USA., Mughal T; Foundation Medicine, Inc., Cambridge, MA, USA., Lamanna N; Department of Medicine, Columbia University Medical Center, New York, USA., Frattini MG; Department of Medicine, Columbia University Medical Center, New York, USA., Heaney ML; Department of Medicine, Columbia University Medical Center, New York, USA., Zelenetz A; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zenz T; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Haematology, University Hospital Zürich and University of Zürich, Zürich, Switzerland., Abdel-Wahab O; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. abdelwao@mskcc.org., Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands. a.p.kater@amc.uva.nl.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands. a.p.kater@amc.uva.nl.
Publikováno v:
Leukemia [Leukemia] 2019 Feb; Vol. 33 (2), pp. 390-402. Date of Electronic Publication: 2018 Jul 23.
Autor:
te Raa GD; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Moerland PD; Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands., Leeksma AC; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Derks IA; Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Yigittop H; MRC-Holland, Amsterdam, The Netherlands., Laddach N; MRC-Holland, Amsterdam, The Netherlands., Loden-van Straaten M; MRC-Holland, Amsterdam, The Netherlands., Navrkalova V; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Trbusek M; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Luijks DM; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Zenz T; Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Skowronska A; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Stankovic T; School of Cancer Sciences, University of Birmingham, Birmingham, UK., van Oers MH; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands., Eldering E; 1] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands [2] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands., Kater AP; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands [3] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands.
Publikováno v:
Cell death & disease [Cell Death Dis] 2015 Aug 06; Vol. 6, pp. e1852. Date of Electronic Publication: 2015 Aug 06.